Literature DB >> 26457787

Developing GRADE outcome-based recommendations about diagnostic tests: a key role in laboratory medicine policies.

Tommaso Trenti, Holger J Schünemann, Mario Plebani.   

Abstract

Harmonisation and risk management policies represent key-issues in modern laboratory medicine as they focus on a more patient-centred delivery of laboratory information based on the recognition of the importance of all steps of the total testing process (TTP) for assuring quality and patient safety. However, a further essential step in project aiming to improve the value of laboratory medicine becomes the assessment of the impact of testing on patient-important outcomes. The grading of recommendations assessment, development and evaluation (GRADE) evidence to decision (EtD) frameworks may provide a systematic and transparent approach for translating the best clinical evidence available into healthcare decisions and recommendations. GRADE is a tool appropriate not only for evaluating test accuracy but also for clinical impact, such as mortality, morbidity, symptoms, and quality of life and therefore it should be applied to the outcome research in laboratory medicine. The application of GRADE requires the recognition that a recommendation about the use of test results should result from a balance between the desirable and the undesirable consequences, including non-health related consequences such as resource utilisation, feasibility, acceptability, equity and other factors. GRADE EtDs, represents a fundamental step in projects designed to improve care quality. Patient-physician-laboratory feedback can be assured through the GRADE process, where the team developing the recommendations should include the "three-parties" representatives; clinicians, laboratorians and patient/consumers. This ensures that the laboratory-patient interaction should not be a one-way process only (information from laboratory to patient) but a two-way process, incorporating patient expectations and feedback.

Entities:  

Mesh:

Year:  2016        PMID: 26457787     DOI: 10.1515/cclm-2015-0867

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  4 in total

1.  Improving accuracy of diagnostic studies in a world with limited resources: a road ahead.

Authors:  Giuseppe Lippi; Mario Plebani
Journal:  Ann Transl Med       Date:  2016-02

Review 2.  Assessing FDG-PET diagnostic accuracy studies to develop recommendations for clinical use in dementia.

Authors:  Marina Boccardi; Cristina Festari; Daniele Altomare; Federica Gandolfo; Stefania Orini; Flavio Nobili; Giovanni B Frisoni
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-04-30       Impact factor: 9.236

3.  Optimizing laboratory test utilization in long-term acute care hospitals.

Authors:  Adan Mora; Brian S Krug; Antony M Grigonis; Amanda Dawson; Yuqing Jing; Samuel I Hammerman
Journal:  Proc (Bayl Univ Med Cent)       Date:  2017-01

Review 4.  Molecular assays for the diagnosis of sepsis in neonates.

Authors:  Mohan Pammi; Angela Flores; James Versalovic; Mariska Mg Leeflang
Journal:  Cochrane Database Syst Rev       Date:  2017-02-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.